Dr. Christoph Volpers
Patent attorney
Dr. Volpers is co-author of numerous scientific publications in the fields of molecular virology, gene therapy, antibody development and signal transduction. He speaks German and English.
- Licensing Executive Society (LES)
Christoph Volpers studied Biology at the University of Mainz and Business Administration at Bradford University. He completed his doctorate in molecular biology in 1995.
After various research activities in academia and industry, including several years at Roche in the USA, Dr. Volpers worked for more than twelve years in patent and licence management in the biopharmaceutical industry. For the last six years, as Director IP Biologics of the Teva-ratiopharm Group, he was responsible worldwide for the organisation and coordination of all patent and licensing processes in the field of biosimilars and innovative biopharmaceutical products. He led an international IP team in Germany, Israel and Australia, which was responsible for an extensive patent portfolio, freedom-to-operate activities, project evaluations and the supervision of ongoing development projects.
Christoph Volpers has been working for the law firm Michalski Hüttermann & Partner in the life sciences sector since the beginning of 2015. He is a German Patent Attorney and European Trademark and Design Attorney.
Back to the team overview